Skip to main content
. 2022 Jun 24;22:571. doi: 10.1186/s12879-022-07538-5

Table 3.

Hospital course and outcomes of patients with E. coli urosepsis

All patients
N = 313
EC-SC group N = 195
(62.3)
EC-RC group
N = 118
(37.7)
P value
Antibiotic administration (days), mean (SD) 7.70 (2.45) 7.40 (2.16) 8.20 (2.80) 0.005
Appropriate empiric antibiotic therapy, n (%) 245 (78.3) 195 (100) 50 (42.4)  < 0.0001
Septic shock, n (%) 15 (4.8) 5 (2.6) 10 (8.5) 0.018
Surgical drainage, n (%) 7 (2.2) 3 (2.5) 4 (2.1) 0.776
Mechanical ventilation, n (%) 16 (5.1) 7 (3.6) 9 (7.6) 0.116
Length of hospital stay (days), mean, (SD) 11.46 (8.50) 9.29 (6.40) 15.04 (10.19)  < 0.0001
Mortality within 30 days, n (%) 27 (8.6) 11 (5.6) 16 (13.6) 0.016
Mortality within 60 days, n (%) 37 (11.8) 14 (7.2) 23 (19.5) 0.001
Mortality within 180 days, n (%) 50 (16) 22 (11.3) 28 (23.7) 0.004
Mortality within 1 year, n (%) 55 (17.6) 25 (12.8) 30 (25.4) 0.005

Data is presented as mean (SD) or number (%)

EC-SC Group—patients with urosepsis caused by E. coli susceptible to 3rd generation cephalosporins

EC-RC Group—patients with urosepsis caused by E. coli resistant to 3rd generations cephalosporins

SD standard deviation